Results from an initial clinical trial for a drug that regenerates inner ear hair cells involved in hearing are promising. — AFP
An American company is developing a treatment to combat loss of hearing.
Based on the concept of regenerative medicine, this drug – still in the clinical trial phase – aims to regenerate the cells responsible for hearing.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
